Skip to main content
. Author manuscript; available in PMC: 2011 Jan 28.
Published in final edited form as: AIDS. 2010 Jan 28;24(3):353–363. doi: 10.1097/QAD.0b013e3283333666

Table 2.

Treatment Differences in Body Composition Measures Between the Drug Conservation (DC) and Viral Suppression (VS) Groups

Outcome Mean Change from Baseline to Month 12A
Mean Change from Baseline through Month 36B
DC VS DC-VS (95% CI) P-Value DC-VS (95% CI) P-Value
Limb fat, absolute change (kg) 0.20 −0.13 0.34 (−0.23, 0.90) 0.25 0.13 (−0.47, 0.73) 0.67
Limb fat, percent change (%)C 9.0 −0.8 9.8 (3.5, 16.1) 0.003 8.7 (2.0, 15.4) 0.01
Lean limb mass (kg) −0.29 −0.18 −0.11 (−0.51, 0.29) 0.60 −0.03 (−0.44, 0.39) 0.90
Total body fat (kg) 0.45 −0.23 0.68 (−0.59, 1.95) 0.29 0.17 (−1.18, 1.52) 0.81
Lean body mass (kg) −0.48 −0.08 −0.40 (−1.11, 0.31) 0.27 −0.25 (−0.99, 0.50) 0.52
VAT (cm2) 3.5 5.5 −2.1 (−13.5, 9.4) 0.72 −1.0 (−14.0, 12.0) 0.88
SAT (cm2) 19.3 5.0 14.3 (−0.1, 28.7) 0.05 10.3 (−4.6, 25.3) 0.17
Patient satisfaction with body imageD −0.3 −0.0 −0.3 (−6.8, 6.3) 0.94 −0.8 (−6.8, 5.2) 0.80
A

Adjusted for sex, race, and the sex-by-race interaction.

B

Estimates and p-values obtained in longitudinal mixed models adjusted for sex, race, and the sex -by-race interaction.

C

Percent change = (limb fat mass at follow-up visit limb fat mass at baseline)/(limb fat mass at baseline) * 100%.

D

Using a visual analogue scale from 0–100, with 0 being the worst and 100 the best.

Abbreviations: CI, confidence interval; DC, Drug Conservation group (episodic ART); SAT, subcutaneous adipose tissue; VAT, visceral adipose tissue; VS, Viral Suppression group (continuous ART)